Tibet AIM Pharm. Inc.
SZSE:002826.SZ
10.97 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 651.884 | 667.039 | 856.734 | 725.459 | 602.619 | 553.255 | 488.774 | 380.293 | 451.922 | 346.995 | 290.726 | 221.108 |
| Kosten van de omzet
| 205.253 | 325.589 | 480.56 | 464.955 | 385.895 | 370.922 | 332.665 | 108.8 | 131.548 | 107.246 | 102.265 | 90.84 |
| Brutowinst
| 446.631 | 341.45 | 376.174 | 260.504 | 216.725 | 182.334 | 156.109 | 271.492 | 320.374 | 239.749 | 188.461 | 130.268 |
| Brutowinstmarge
| 0.685 | 0.512 | 0.439 | 0.359 | 0.36 | 0.33 | 0.319 | 0.714 | 0.709 | 0.691 | 0.648 | 0.589 |
| Onderzoek- en ontwikkelingskosten
| 15.483 | 19.658 | 13.354 | 11.39 | 6.848 | 4.997 | 16.409 | 3.593 | 2.177 | 5.541 | 7.472 | 11.138 |
| Algemene en administratieve kosten
| 13.22 | 17.06 | 24.7 | 29.249 | 18.496 | 18.517 | 13.06 | 14.096 | 19.979 | 16.505 | 10.934 | 12.684 |
| Verkoop- en marketingkosten
| 313.366 | 221.238 | 270.673 | 172.566 | 142.871 | 111.457 | 99.184 | 182.156 | 215.958 | 155.534 | 123.481 | 82.623 |
| Verkoop-, algemene en administratieve kosten
| 326.586 | 291.327 | 295.373 | 201.815 | 161.368 | 129.974 | 112.243 | 196.251 | 235.937 | 172.04 | 134.416 | 95.307 |
| Overige kosten
| 43.061 | 6.96 | 11.288 | 4.702 | 3.405 | -0.039 | 2.137 | 2.816 | 16.52 | 11.523 | 12.62 | 12.104 |
| Bedrijfskosten
| 385.13 | 317.946 | 320.015 | 217.908 | 171.62 | 134.932 | 131.083 | 205.334 | 263.308 | 191.833 | 156.105 | 117.975 |
| Bedrijfsresultaat
| 61.501 | 23.505 | 55.729 | 48.637 | 43.126 | 47.704 | 26.857 | 65.101 | 47.152 | 45.458 | 29.965 | 14.238 |
| Bedrijfsresultaat ratio
| 0.094 | 0.035 | 0.065 | 0.067 | 0.072 | 0.086 | 0.055 | 0.171 | 0.104 | 0.131 | 0.103 | 0.064 |
| Totaal overige inkomsten en kosten netto
| -1.126 | 0.095 | 0.973 | 1.376 | 4.222 | 0.034 | 2.137 | 2.816 | -5.321 | 10.661 | 12.569 | 11.957 |
| Inkomen voor belasting
| 60.376 | 23.6 | 56.703 | 50.013 | 47.348 | 47.737 | 28.993 | 67.917 | 63.197 | 56.119 | 42.534 | 26.195 |
| Inkomen voor belasting ratio
| 0.093 | 0.035 | 0.066 | 0.069 | 0.079 | 0.086 | 0.059 | 0.179 | 0.14 | 0.162 | 0.146 | 0.118 |
| Belastingkosten
| 12.916 | 7.874 | 10.587 | 6.54 | 6.257 | 10.408 | 3.738 | 7.44 | 7.839 | 6.089 | 8.678 | 4.371 |
| Nettowinst
| 45.929 | 15.386 | 44.135 | 42.476 | 41.091 | 37.329 | 25.255 | 60.477 | 55.358 | 50.03 | 32.373 | 19.707 |
| Nettowinstmarge
| 0.07 | 0.023 | 0.052 | 0.059 | 0.068 | 0.067 | 0.052 | 0.159 | 0.122 | 0.144 | 0.111 | 0.089 |
| WPA (Winst Per Aandeel)
| 0.25 | 0.08 | 0.23 | 0.22 | 0.22 | 0.2 | 0.13 | 0.32 | 0.38 | 0.37 | 0.24 | 0.39 |
| Verwaterde WPA
| 0.25 | 0.08 | 0.23 | 0.22 | 0.22 | 0.2 | 0.13 | 0.32 | 0.38 | 0.37 | 0.24 | 0.39 |
| EBITDA
| 82.514 | 48.914 | 80.214 | 76.365 | 65.763 | 61.437 | 39.85 | 76.986 | 75.687 | 61.02 | 47.815 | 32.719 |
| EBITDA ratio
| 0.127 | 0.073 | 0.094 | 0.105 | 0.109 | 0.111 | 0.082 | 0.202 | 0.167 | 0.176 | 0.164 | 0.148 |